Mandate

Vinge advisor to the lead investors in connection with Kry’s USD 300m financing round

The financing round was led by CPP Investments (CPPIB) and Fidelity Management & Research Company LLC with participation from existing investors, including the Ontario Teachers’ Pension Plan, Index Ventures, Accel, Creandum and Project A.

Vinge has acted as lead counsel to the lead investors CPP Investments (CPPIB) and Fidelity Management & Research Company LLC in connection with the financing round.

 

Kry will use the investment to scale its platform, building on both its operations as a healthcare provider and its innovative software offerings as well as further geographic expansion. This will bring the benefits of its technology to millions more patients across Europe. Kry, which has been growing rapidly since it was founded in 2015, has helped over three million patients access healthcare to date.

 

The company grew over 100% year-on-year in 2020 in response to supporting patients and healthcare systems across Europe during the pandemic. The new funding will help the company meet the increasing patient demand for their virtual healthcare services and fulfil its vision of making high-quality healthcare accessible for all.

 

Vinge’s team included partners Johan Larsson and Matthias Pannier, together with Karl Klackenberg, Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Mathilda Persson and Karl-Hugo Engdahl (IT & Data Protection) and Sara Strandberg (Employment).  

Related

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026